Novartis | NOVN - Eigenkapital Und Reserven

Aktienkurs
117.22
Täglich Wechseln
-2.28 -1.91%
Monatlich
-7.31%
Jährlich
17.48%
Q1 Prognose
118.31




Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Alcon AG USD 22.03B 52M 2025-12
Almirall EUR 1.49B 24.03M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Autolus Therapeutics Ltd USD 265.45M 81.01M 2025-09
Bayer EUR 25.95B 3.75B 2025-12
Biogen USD 18.21B 573.5M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Fresenius EUR 18.62B 320M 2025-09
Fresenius Medical Care EUR 249.82M 12.7B 2025-12
Galapagos EUR 3.24B 788.91M 2025-12
Genmab DKK 5.3B 6M 2025-06
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
GRIFOLS EUR 5.29B 108.05M 2025-12
Hikma Pharmaceutical USD 2.59B 42M 2025-12
J&J USD 78.47B 0 2025-09
Lonza CHF 9.33B 23M 2024-12
Merck EUR 28.59B 344M 2025-12
Merck USD 51.85B 2.79B 2025-09
Novartis USD 44.75B 2.7B 2025-09
Novartis USD 44.33B 2.28B 2025-09
Novo Nordisk DKK 194.05B 24.15B 2025-12
Orion EUR 1.28B 265.4M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Philips EUR 10.58B 204M 2025-09
Recordati EUR 1.93B 57.32M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
UCB EUR 10.03B 1.08B 2024-12